Green Sands Equity

Established in 2015, Green Sands Equity is a boutique investment firm headquartered in San Francisco, California. It specializes in growth capital investments, strategic buyouts, and advisory services across various sectors including technology, healthcare, and emerging technologies.

Bill Chua

Managing Director and Board Member

Sergio Fernandez de Cordova

Managing Director

Jenya Gusovsky

Venture Partner

Laurence Kalinsky

Managing Director

Reema Khan

Founder and CEO

Adrian Leuenberger

Managing Partner, Green Sands Switzerland

Shadi Sadeek Sanbar

Managing Director and Board Member

Sajid Siddiqi

Managing Director

Davide Venturelli Ph.D

Partner

32 past transactions

Axyon AI

Venture Round in 2025
Axyon AI SRL is a fintech company specializing in artificial intelligence-based software solutions for the banking and investment management sectors. Founded in 2016 and headquartered in Modena, Italy, with an office in London, Axyon AI develops advanced web applications that enhance decision-making for asset managers and corporate banks. Its flagship product, Axyon SynFinance, provides predictive analytics for liquidity, market conditions, and lead generation tailored for loan syndication desks. Another significant offering, Axyon IRIS, delivers periodic predictions on key financial metrics such as volatility and various performance ratios, aiding asset managers in strategy formulation. By leveraging deep learning technologies, Axyon AI creates customized predictive models that are designed to improve portfolio management and generate alpha, thereby facilitating innovative investment and risk management processes.

Stepful

Series B in 2024
Stepful is a platform that enables individuals with only a high school diploma to train for and secure entry-level positions in the healthcare sector. It offers online courses, hands-on clinical sessions, and job placement assistance.

Axyon AI

Venture Round in 2024
Axyon AI SRL is a fintech company specializing in artificial intelligence-based software solutions for the banking and investment management sectors. Founded in 2016 and headquartered in Modena, Italy, with an office in London, Axyon AI develops advanced web applications that enhance decision-making for asset managers and corporate banks. Its flagship product, Axyon SynFinance, provides predictive analytics for liquidity, market conditions, and lead generation tailored for loan syndication desks. Another significant offering, Axyon IRIS, delivers periodic predictions on key financial metrics such as volatility and various performance ratios, aiding asset managers in strategy formulation. By leveraging deep learning technologies, Axyon AI creates customized predictive models that are designed to improve portfolio management and generate alpha, thereby facilitating innovative investment and risk management processes.

TreQ

Seed Round in 2024
TreQ is a manufacturing company specializing in the production of bespoke quantum computing clusters. These clusters are designed to tackle complex computational problems that are currently beyond the capabilities of classical computers. By leveraging quantum mechanics, TreQ's systems can perform a single calculation that would be impractical or impossible for traditional computers, thereby enabling businesses and institutions to optimize asset allocation, minimize risk, and make data-driven decisions more effectively.

Ephos

Seed Round in 2024
Ephos specializes in developing integrated photonic circuits using glass technology. Its focus is on minimizing signal loss and enabling innovative device designs for classical and quantum computing applications, communications, and sensing. The company's proprietary manufacturing process ensures high-quality production tailored to client needs in the computational infrastructure sector.

Vectara

Series A in 2024
Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.

Elve

Series A in 2024
Elve is a manufacturer specializing in high-efficiency, lightweight millimeter wave and near-terahertz power amplifiers designed to enhance wireless connectivity. The company focuses on developing advanced technologies that facilitate fiber-like wireless internet links, thereby improving the overall online experience for users. By integrating agile manufacturing techniques into their vacuum electronic devices, Elve aims to provide innovative solutions that support widespread connectivity in various applications.

Stepful

Series A in 2024
Stepful is a platform that enables individuals with only a high school diploma to train for and secure entry-level positions in the healthcare sector. It offers online courses, hands-on clinical sessions, and job placement assistance.

Fizz

Series B in 2023
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

Sagence AI

Series A in 2023
Analog Inference is a company focused on advancing neural computing through innovative technology. Founded by experienced professionals from the computing industry and supported by Khosla Ventures, the company is developing its first generation of products. It specializes in deep sub-threshold analog in-memory computation, which allows for the execution of complex neural networks at full resolution while maintaining low latency and eliminating the need for active cooling. This technology enables the performance of data-center-grade artificial intelligence workloads with significantly reduced power consumption, facilitating the deployment of server-class networks in more cost-effective devices.

Paradromics

Series A in 2023
Paradromics, Inc. is a company focused on developing advanced brain-machine interfaces aimed at transmitting data between the brain and external devices. Founded in 2015 and based in Austin, Texas, Paradromics manufactures implantable systems that facilitate neural data decoding, converting intricate neural recordings into data streams suitable for various neural prostheses. The company's technology is designed to enhance data transmission rates, providing high-volume, bidirectional data streaming capabilities. This innovation aims to assist individuals with neurodegenerative diseases and other neurological conditions by compensating for the loss of biological connectivity. In addition to its core products, Paradromics also develops applications to support its technology solutions.

PASQAL

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Elve

Venture Round in 2023
Elve is a manufacturer specializing in high-efficiency, lightweight millimeter wave and near-terahertz power amplifiers designed to enhance wireless connectivity. The company focuses on developing advanced technologies that facilitate fiber-like wireless internet links, thereby improving the overall online experience for users. By integrating agile manufacturing techniques into their vacuum electronic devices, Elve aims to provide innovative solutions that support widespread connectivity in various applications.

ArsenalBio

Series B in 2022
ArsenalBio is a programmable cell therapy company established in 2019, focused on developing and commercializing innovative immune cell therapies, particularly for cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create multifunctional T-cell therapies. ArsenalBio's approach involves the precise insertion of large synthetic DNA sequences, enabling the generation of next-generation autologous T-cell therapies. By integrating these cutting-edge methods, ArsenalBio aims to enhance the effectiveness and safety of immune cell therapies, reduce costs for healthcare providers, and improve market access, ultimately broadening patient outcomes and making these therapies more widely available.

Qenta

Venture Round in 2022
Qenta is a financial technology platform that provides cashless payment processing and global payments orchestration for traditional and digital channels. Founded in 2016 and headquartered in Houston, Texas, the company supports Pay In and Pay Out transactions, including eWallet top-ups, remittances, cross-border invoice settlements, and foreign exchange services. Its platform processes payments across cash, mobile money, and local alternative payment methods, and uses blockchain technology to create a secure, compliant ecosystem for businesses and citizens in Austrian and Central European markets as well as emerging regions in Africa, South Asia, and South America.

Stepful

Venture Round in 2022
Stepful is a platform that enables individuals with only a high school diploma to train for and secure entry-level positions in the healthcare sector. It offers online courses, hands-on clinical sessions, and job placement assistance.

Good Chemistry

Seed Round in 2022
Good Chemistry Company is focused on enhancing health, sustainability, and environmental quality through advanced material design. The company has developed QEMIST Cloud, a cloud-based computational chemistry platform that enables developers to create chemical simulation applications and workflows. By leveraging cutting-edge algorithms in quantum chemistry, machine learning, and quantum computing, Good Chemistry provides tools that allow for the rapid and accurate prediction of chemical properties, significantly accelerating the material design process.

Colossal Biosciences

Series A in 2022
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Leveraging gene editing technologies, including CRISPR, it pursues de-extinction initiatives such as reviving the woolly mammoth and aims to aid ecosystem restoration and biodiversity. The company develops technologies to revive species and repopulate ecosystems critical to environmental health and future human needs.

Devoted Health

Series D in 2021
Founded in 2017, Devoted Health is dedicated to enhancing the health and well-being of older Americans by offering integrated Medicare Advantage plans. They provide personalized care through a combination of local providers, virtual and in-home care, dedicated guides, and advanced technology.

USA Rare Earth

Venture Round in 2021
Founded in 2019, USA Rare Earth is a vertically integrated company focused on processing and exploration of minerals. It operates the Round Top Heavy Rare Earth project with an 80% interest, which hosts critical heavy rare earth elements, lithium, gallium, uranium, and beryllium. The company aims to be one of the lowest cost producers globally, supporting U.S. defense industries and consumer electronics.

Commure

Series D in 2021
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.

Noble Money

Seed Round in 2021
Noble Money is a digital currency company focused on broadening the accessibility of sound money for individuals worldwide. The company aims to facilitate the adoption of digital currencies, starting with governmental integration. It specializes in the tokenization of digital currencies, working to enhance their usability and acceptance in various sectors. Through its initiatives, Noble Money aspires to make digital currencies a viable option for everyday transactions, ultimately promoting financial inclusivity and innovation in the monetary landscape.

Senti Biosciences

Series B in 2021
Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

AST SpaceMobile

Venture Round in 2021
AST SpaceMobile develops and manufactures satellites for a global broadband cellular network in space. This network directly connects with standard, unmodified mobile devices, aiming to eliminate connectivity gaps and bring broadband to the billions currently unconnected.

ReViral

Series C in 2020
ReViral Ltd is a biotechnology company based in Stevenage, United Kingdom, specializing in the discovery and development of antiviral drugs targeting respiratory syncytial virus (RSV). Founded in 2011, ReViral is focused on creating innovative first-in-class compounds, including a highly potent fusion inhibitor designed specifically for treating severe RSV infections, particularly in vulnerable populations such as neonates. By advancing these novel antiviral treatments, ReViral aims to address significant unmet medical needs and expand the antiviral market, ultimately improving patient outcomes for those affected by RSV.

Praxis Precision Medicines

Series C in 2020
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders marked by neuronal imbalance. Established in 2015 and headquartered in Cambridge, Massachusetts, the company leverages genetic insights to create innovative treatments for neurological and psychiatric conditions. Its leading product candidates include PRAX-114, an allosteric modulator targeting GABAA receptors, currently undergoing Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, along with PRAX-222, an antisense oligonucleotide aimed at treating patients with SCN2A epilepsy, and a program focused on KCNT1-related epilepsy. The company has established collaborations and licensing agreements with various organizations to enhance its research and development efforts.

Encoded Therapeutics

Series D in 2020
Encoded Therapeutics is a biotechnology company focused on precision gene therapies to treat a broad range of severe genetic disorders. It develops therapies and a platform that identifies human genome sequences that regulate gene expression using screening and computational approaches. The company's pipeline targets conditions across multiple pathways, including neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular disease, aiming to help medical practitioners treat patients and improve outcomes. Based in South San Francisco, California, Encoded Therapeutics was founded in 2014 and was previously known as Encoded Genomics.

Didi

Venture Round in 2020
Didi Chuxing, founded in 2012 in Beijing, is a leading mobile transportation platform providing app-based services such as taxi hailing, private car-hailing, social ride-sharing, car rental, and enterprise solutions. With over 450 million users and daily orders reaching 25 million, Didi offers a variety of mobility options to optimize resource allocation through big data-driven algorithms. The company aims to address transportation, environmental, and employment challenges by collaborating with communities and partners. Acquiring Uber China in 2016, Didi has over 21 million drivers and car owners on its platform, generating income while offering convenient transportation solutions to users worldwide.

BedRock Systems

Venture Round in 2020
Our Mission is to BedRock the world’s critical systems from Edge to Server and Cloud implementing the most trusted Provably Unbreakable™ and Programmable Hypervisor platform with Active Security™

Whiterabbit.ai

Venture Round in 2020
Whiterabbit.ai specializes in creating artificial intelligence-driven software designed to enhance the early detection and diagnosis of breast cancer. The company's platform aims to transform the cancer screening process by addressing key challenges, including patient compliance and provider accuracy. By leveraging advanced technology, Whiterabbit.ai seeks to improve patient engagement and overall care quality, ultimately enhancing outcomes in cancer diagnosis and treatment.

1QBit

Series B in 2017
1QBit is a quantum computing software company that develops a computational optimization platform using quantum-inspired computing to address industrial challenges. The platform is hardware-agnostic and supports routing and scheduling, portfolio management, molecular similarity analysis, and risk assessment, enabling organizations across industries to tackle complex decision-making and improve operational efficiency.

Lyft

Venture Round in 2017
Lyft is a transportation company that designs, markets, and operates a mobile application that connects riders with drivers for private and shared rides, with in-app payment and the ability to schedule trips in advance. The platform has expanded to multimodal options, including bike- and scooter-sharing, to provide integrated transportation options. Founded in 2013 and publicly listed in 2019, Lyft is the second-largest ride-sharing service provider in the United States and Canada, serving diverse user segments including college, university, and corporate communities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.